Intermittent administration of salmeterol does not induce tolerance to the bronchoprotective effect in exercise induced bronchoconstriction Source: Eur Respir J 2003; 22: Suppl. 45, 497s Year: 2003
Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children Source: Eur Respir J 2006; 28: 291-295 Year: 2006
Effect of formoterol on exercise tolerance in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 214s Year: 2004
Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline Source: Eur Respir J 2002; 19: 865-871 Year: 2002
Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol Source: Eur Respir J 2001; 17: 368-373 Year: 2001
Effect of budesonide/formoterol, budesonide and terbutaline on exercise-induced bronchoconstriction in mild intermittent asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011
Mechanisms of improved exercise tolerance in COPD in response to tiotropium Source: Eur Respir J 2002; 20: Suppl. 38, 288s Year: 2002
Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006
Comparative effects of formoterol monotherapy versus formoterol plus tiotropium on dynamic hyperinflation and exercise tolerance in COPD Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance Year: 2009
Over time effect of montelukast in asthmatic children with exercise-induced bronchoconstriction Source: Eur Respir J 2005; 26: Suppl. 49, 162s Year: 2005
Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Effects of salmeterol, formoterol and placebo on pulmonary function and symptom recovery after histamine provocation in mild asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 710s Year: 2004
Effects of inhaled formoterol on dynamic hyperinflation during and after incremental treadmill exercise in patients with advanced COPD Source: Eur Respir J 2006; 28: Suppl. 50, 172s Year: 2006
Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 108s Year: 2002
Effects of tiotropium bromide on bronchial obstruction and exercise tolerance in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006
NVA237 has similar efficacy as tiotropium bromide against methacholine-induced bronchoconstriction and less systemic effect on cardiovascular variables in an anaesthetized rabbit model Source: Eur Respir J 2006; 28: Suppl. 50, 436s Year: 2006
The protective effect of a nasal corticosteroid on exercise induced bronchoconstriction in cold air Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010
Time effect of montelukast in the prevention of exercise-induced bronchoconstriction in children Source: Eur Respir J 2001; 18: Suppl. 33, 119s Year: 2001
Inhaled corticosteroid improved the perception of dyspnea during methacholine induced bronchoconstriction and changed the hypoxic ventilatory response in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002
Acute effect of formoterol, salmeterol, albuterol, oxitropium bromide and placebo on FEV1, inspiratory capacity and dyspnoea in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 380s Year: 2001